February 12, 2026 – Siemens Healthineers and Mayo Clinic are increasing their strategic collaboration to enhance affected person look after neurodegenerative illnesses and the therapy of prostate most cancers and metastatic liver tumors. The 2 organizations have signed an settlement that can enhance look after folks with these illnesses and develop entry to new imaging and interventional applied sciences.

Preliminary areas for collaboration embody:

• Neurodegenerative illness: Growing and clinically utilizing MRI protocols with synthetic intelligence (AI) for improved diagnostic accuracy and affected person monitoring.
• Innovation of surgical care pathways: Making use of digital twin applied sciences to reimagine how sufferers expertise surgical procedure, bettering their care and bettering operational effectivity.
• Prostate most cancers: Collaboratively discover the function of AI in minimizing biopsies and methods to combine minimally invasive, superior imaging into diagnostic and therapeutic procedures.
• Minimally invasive, image-guided interventional suites: Creating areas to make use of the newest image-guided applied sciences for the correct detection and therapy of liver metastases.
• Extremely-high-field MRI Innovation Heart: Using ultra-high-field MRI protocols, profiting from the expertise’s excessive decision and enhanced distinction, for diagnostic and surgical planning in sufferers with advanced neurological illnesses.
• Entire Physique PET/CT & PET/MR innovation middle: Using whole-body PET/CT, emphasizing theranostic therapy for sure cancers, with simultaneous anatomical and metabolic MR imaging, to allow correct diagnostic and therapeutic planning.

Proceed studying